Screen Shot 2016-08-26 at 2.28.48 PM

Actress Sarah Jessica Parker has cut ties with the Mylan, the pharmaceutical company that makes the emergency allergy treatment EpiPen, after public outrage over their price hike. Sarah’s 13-year-old son James has severe nut allergies, so the EpiPen was a save-all for their family.

The company is facing criticism after reports that the price for the EpiPen has increased 400% since 2008. What was once $100 eight years ago, is a little more than $500 today.

Sarah Jessica Parker took to her Instagram to talk about the issue many parents face.

What do you think of her action? Tell us in the comments below!

All Photos: sarahjessicaparker via Instagram